1325 — Universal Income Statement
0.000.00%
Last trade - 00:00
- TWD2.33bn
- TWD802.07m
- TWD405.76m
- 71
- 21
- 16
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 773 | 4,057 | 1,191 | 554 | 406 |
Cost of Revenue | |||||
Gross Profit | 83.7 | 2,706 | 440 | 43.7 | -0.375 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 739 | 1,532 | 821 | 559 | 454 |
Operating Profit | 33.6 | 2,525 | 370 | -5.02 | -48.5 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 44 | 2,531 | 390 | 20.5 | 20.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 34.7 | 2,015 | 277 | 13.5 | 12.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 36.2 | 1,975 | 278 | 16.6 | 17.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 36.2 | 1,975 | 278 | 16.6 | 17.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.425 | 22.9 | 3.26 | 0.141 | 0.204 |
Dividends per Share |